StarStarter Rx Research

StarStarterRx-logo_452x172

Research

StarStarter Rx’s core therapeutic method is a game-based approach to a decades-old area of clinical and neuroscientific research known as Attention Bias Modification (ABM).

The human brain is uniquely predisposed to subconscious, sub-second processing of faces. StarStarter Rx uses facial expression and gamification to re-train emotional and attentional patterns that can drive persistent feelings of social anxiety.

line-yellow

StarStarter Rx’s proprietary game mechanics have been designed and
optimized through a decade of neuroscientific research using:

StarStarter Rx is currently being investigated as a cognitive behavioral therapy in clinical trials and will be submitted for FDA’s review as a treatment for Social Anxiety Disorder. The foundational research into StarStarter Rx’s mechanism of action spans 7 randomized controlled trials and more than 230 study participants.

Our most recent randomized controlled trial, which leveraged a gold-standard placebo control, showed a robust impact on social anxiety symptoms:

  • In the active arm, more than 90% of participants showed reductions in LSAS anxiety symptoms, averaging 33%

  • The active arm (N=50) resulted in a mean LSAS reduction significantly above that of the control group (N=40)

  • 68% of participants saw a clinically meaningful reduction in their anxiety severity level

  • 38% showed reductions to sub-clinical cutoffs

Warnings and Limitations
Caution: StartStarter Rx is limited by Federal Law to investigational use only. StartStarter Rx is currently being investigated in various clinical trials to assess its safety and efficacy. For more information, please contact Arcade Therapeutics, Inc.